TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Trial of Transcervical Foley Balloon Compared to Controlled Release Prostaglandin (Cervidil) for Labor Induction and Cervical Ripening in Term and Near Term Women
Brief Summary: OBJECTIVE: To assess the efficacy of transcervical Foley catheter compared to controlled release prostaglandin (Cervidil™) for cervical ripening in term and near term women presenting for labor induction.

HYPOTHESIS: In term and near term women presenting for labor induction, transcervical Foley catheter will decrease the mean time from induction to delivery by six hours compared to controlled release prostaglandin (Cervidil™).


Options:
A: Intervention Type: DRUG; Name: low dose oxytocin; Assigned to Arm(s): N/A
B: Arm Label: FOLEY BALLOON; Type: ACTIVE_COMPARATOR; Interventions: Device: FOLEY BALLOON | Arm Label: CERVIDIL; Type: ACTIVE_COMPARATOR; Interventions: Drug: CERVIDIL (Dinoprostone) | Intervention Type: DRUG; Name: CERVIDIL (Dinoprostone); Assigned to Arm(s): CERVIDIL | Intervention Type: DEVICE; Name: FOLEY BALLOON; Assigned to Arm(s): FOLEY BALLOON
C: Arm Label: Foley Bulb plus Misoprostol; Type: EXPERIMENTAL; Interventions: Device: Foley bulb | Arm Label: Misoprostol; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Foley bulb; Assigned to Arm(s): Foley Bulb plus Misoprostol
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: ARD (Atad Ripener Device) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: AID (Atad double balloon Instillation Device) | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Device: folly catheter | Intervention Type: DEVICE; Name: ARD (Atad Ripener Device); Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: AID (Atad double balloon Instillation Device); Assigned to Arm(s): 2 | Intervention Type: DEVICE; Name: folly catheter; Assigned to Arm(s): 3

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Trial of Transcervical Foley Balloon Compared to Controlled Release Prostaglandin (Cervidil) for Labor Induction and Cervical Ripening in Term and Near Term Women
Brief Summary: OBJECTIVE: To assess the efficacy of transcervical Foley catheter compared to controlled release prostaglandin (Cervidil™) for cervical ripening in term and near term women presenting for labor induction.

HYPOTHESIS: In term and near term women presenting for labor induction, transcervical Foley catheter will decrease the mean time from induction to delivery by six hours compared to controlled release prostaglandin (Cervidil™).


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: misoprostol | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: dinoprostone | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Device: Bard Catheter (balloon catheter) | Intervention Type: DRUG; Name: misoprostol; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: dinoprostone; Assigned to Arm(s): 2 | Intervention Type: DEVICE; Name: Bard Catheter (balloon catheter); Assigned to Arm(s): 3
B: Arm Label: FOLEY BALLOON; Type: ACTIVE_COMPARATOR; Interventions: Device: FOLEY BALLOON | Arm Label: CERVIDIL; Type: ACTIVE_COMPARATOR; Interventions: Drug: CERVIDIL (Dinoprostone) | Intervention Type: DRUG; Name: CERVIDIL (Dinoprostone); Assigned to Arm(s): CERVIDIL | Intervention Type: DEVICE; Name: FOLEY BALLOON; Assigned to Arm(s): FOLEY BALLOON
C: Arm Label: Misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol | Arm Label: Foley Catheter; Type: ACTIVE_COMPARATOR; Interventions: Device: Foley Catheter | Intervention Type: DEVICE; Name: Foley Catheter; Assigned to Arm(s): Foley Catheter | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol
D: Arm Label: folye catheter plus vaginal IMN; Type: EXPERIMENTAL; Interventions: Device: foley catheter, Drug: Vaginal IMN | Arm Label: Misoprostol vaginally; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol | Intervention Type: DEVICE; Name: foley catheter; Assigned to Arm(s): folye catheter plus vaginal IMN | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol vaginally | Intervention Type: DRUG; Name: Vaginal IMN; Assigned to Arm(s): folye catheter plus vaginal IMN

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Management of Depression in Primary Health Care: a Controlled Trial on the Effectiveness of Regular, Structured, Patient-centered Visits
Brief Summary: Most people in Sweden with mild to moderate depression are treated in primary care, but follow-up is unstructured, and we know little about whether structured, follow-up would affect the prognosis for depression and working life. The purpose of this study is to determine the effectiveness of regular, structured, patient-centered visits on mild to moderate depression.


Options:
A: Intervention Type: BEHAVIORAL; Name: Care manager outreach and monitoring; Assigned to Arm(s): N/A
B: Arm Label: Structured patient visits; Type: OTHER; Interventions: Behavioral: Structured patient-centered follow up of depression | Arm Label: Treatment as usual; Type: OTHER; Interventions: Behavioral: Structured patient-centered follow up of depression | Intervention Type: BEHAVIORAL; Name: Structured patient-centered follow up of depression; Assigned to Arm(s): Structured patient visits, Treatment as usual
C: Arm Label: Phase B; Type: EXPERIMENTAL; Interventions: Drug: OPC-34712 + ADT, Drug: Placebo + ADT | Arm Label: Phase A; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo + ADT | Intervention Type: DRUG; Name: OPC-34712 + ADT; Assigned to Arm(s): Phase B | Intervention Type: DRUG; Name: Placebo + ADT; Assigned to Arm(s): Phase B | Intervention Type: DRUG; Name: Placebo + ADT; Assigned to Arm(s): Phase A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness Based Cognitive Therapy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Health Enhancement Program and medication management | Intervention Type: BEHAVIORAL; Name: Mindfulness Based Cognitive Therapy; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Health Enhancement Program and medication management; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Management of Depression in Primary Health Care: a Controlled Trial on the Effectiveness of Regular, Structured, Patient-centered Visits
Brief Summary: Most people in Sweden with mild to moderate depression are treated in primary care, but follow-up is unstructured, and we know little about whether structured, follow-up would affect the prognosis for depression and working life. The purpose of this study is to determine the effectiveness of regular, structured, patient-centered visits on mild to moderate depression.


Options:
A: Arm Label: Implementation intervention; Type: EXPERIMENTAL; Interventions: Other: Implementation intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Implementation intervention; Assigned to Arm(s): Implementation intervention
B: Arm Label: Structured patient visits; Type: OTHER; Interventions: Behavioral: Structured patient-centered follow up of depression | Arm Label: Treatment as usual; Type: OTHER; Interventions: Behavioral: Structured patient-centered follow up of depression | Intervention Type: BEHAVIORAL; Name: Structured patient-centered follow up of depression; Assigned to Arm(s): Structured patient visits, Treatment as usual
C: Arm Label: PHR Group; Type: ACTIVE_COMPARATOR; Interventions: Other: SANOIA Website | Arm Label: Non-PHR Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: SANOIA Website; Assigned to Arm(s): PHR Group
D: Arm Label: Routine data collection; Type: ACTIVE_COMPARATOR; Interventions: Other: Routine Data collection | Arm Label: Feedback of patient-reported outcomes; Type: EXPERIMENTAL; Interventions: Other: Routine Data collection, Other: Feedback of patient-reported outcomes | Intervention Type: OTHER; Name: Routine Data collection; Assigned to Arm(s): Feedback of patient-reported outcomes, Routine data collection | Intervention Type: OTHER; Name: Feedback of patient-reported outcomes; Assigned to Arm(s): Feedback of patient-reported outcomes

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Brief Summary: The purpose of this study is to determine the safety and efficacy of an oral testosterone undecanoate formulation for use as testosterone-replacement therapy in men with low testosterone.


Options:
A: Arm Label: AndroGel 1.62%; Type: ACTIVE_COMPARATOR; Interventions: Drug: AndroGel® | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: AndroGel®; Assigned to Arm(s): AndroGel 1.62% | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Reandron 1000 | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Reandron 1000; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2
C: Arm Label: Oral testosterone undecanoate (TU); Type: EXPERIMENTAL; Interventions: Drug: Oral testosterone undecanoate | Arm Label: topical testosterone gel; Type: ACTIVE_COMPARATOR; Interventions: Drug: topical testosterone gel | Intervention Type: DRUG; Name: Oral testosterone undecanoate; Assigned to Arm(s): Oral testosterone undecanoate (TU) | Intervention Type: DRUG; Name: topical testosterone gel; Assigned to Arm(s): topical testosterone gel
D: Arm Label: Testosterone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Testosterone Gel (Androgel) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Testosterone Gel (Androgel); Assigned to Arm(s): Testosterone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Community Level Deployment of Rapid Diagnostic Tests for Malaria in Afghanistan: Cluster Randomised Trial
Brief Summary: Malaria is a common, but decreasing, cause of fever in endemic areas. The use of rapid diagnostic tests could improve treatment of malaria at the local community level. Deployment of these tests is, however, a considerable cost. The aim of the study is to evaluate their effect on improving treatment of fever when used by Community Health Workers in Afghanistan. In phase I of the study, the hypothesis is that an RDT diagnosis deployed with standard training and support will improve the accuracy of treatment applied to fever by community health workers when compared to a diagnosis that is based on symptoms alone. In Phase II of the study, the hypothesis is that the accuracy of treatment can be improved by additional training and supportive interventions given to community health workers compared to those who have only had standard training.


Options:
A: Arm Label: Current Practice; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Arm; Type: ACTIVE_COMPARATOR; Interventions: Device: Malaria Rapid Diagnostic test | Intervention Type: DEVICE; Name: Malaria Rapid Diagnostic test; Assigned to Arm(s): Intervention Arm
B: Arm Label: nothing at home level; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Home management of malaria; Type: EXPERIMENTAL; Interventions: Other: home/community case management | Arm Label: Home management of malaria and pneumonia; Type: EXPERIMENTAL; Interventions: Other: home/community case management | Intervention Type: OTHER; Name: home/community case management; Assigned to Arm(s): Home management of malaria, Home management of malaria and pneumonia
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: Rapid diagnostic test for malaria | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: Rapid diagnostic test for malaria | Intervention Type: DEVICE; Name: Rapid diagnostic test for malaria; Assigned to Arm(s): 1, 2
D: Arm Label: rapid diagnostic test; Type: ACTIVE_COMPARATOR; Interventions: Device: Rapid diagnostic test, Drug: Lumartem | Arm Label: Presumptive malaria treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Rapid diagnostic test; Assigned to Arm(s): rapid diagnostic test | Intervention Type: DRUG; Name: Lumartem; Assigned to Arm(s): rapid diagnostic test

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Web-based IHCA for Successful Home Dialysis
Brief Summary: This study involves Chronic Kidney Disease patients that must choose the type of dialysis therapy they ultimately wish to perform. These patients receive education regarding dialysis types from nurses and Nephrologists at a Kidney Function Program. The investigators have developed a web-based Interactive Health Communication Application that could provide more education and support to patients about their dialysis choices. The investigators will compare patients that will receive usual care dialysis education versus patients that will receive additional education through this web-based application. The investigators feel that this tool may increase the proportion of patients who start home dialysis, which offers advantages such as improvement in quality of life and deceased overall healthcare costs, over hospital hemodialysis.


Options:
A: Arm Label: usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Health Communication Application; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Interactive Health Communication Application | Intervention Type: BEHAVIORAL; Name: Interactive Health Communication Application; Assigned to Arm(s): Health Communication Application
B: Arm Label: ICT based monitoring group; Type: EXPERIMENTAL; Interventions: Device: Feedback using ICT based monitoring system | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Feedback using ICT based monitoring system; Assigned to Arm(s): ICT based monitoring group
C: Arm Label: Multi-component Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Action-focused problem-solving, Device: Electronic pillbox monitoring, dose reminders, and feedback | Arm Label: Attention control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Action-focused problem-solving; Assigned to Arm(s): Multi-component Intervention | Intervention Type: DEVICE; Name: Electronic pillbox monitoring, dose reminders, and feedback; Assigned to Arm(s): Multi-component Intervention
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: iChoose Kidney Decision Aid; Type: EXPERIMENTAL; Interventions: Behavioral: iChoose Kidney Decision Aid | Intervention Type: BEHAVIORAL; Name: iChoose Kidney Decision Aid; Assigned to Arm(s): iChoose Kidney Decision Aid

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Personality and Eating Behaviors in Morbidly Obese Patients
Brief Summary: The aim of this randomized controlled trial is assess the effect of a psychological based treatment model on eating behaviors and motivation for lifestyle changes in morbidly obese patients undergoing bariatric surgery.

Hypothesis: As compared with usual care, Cognitive Behavioral Therapy and Motivational interviewing-based (CBT/MI) intervention program will reduce dysfunctional eating behaviors and increase pre-surgical intrinsic motivation for lifestyle changes.


Options:
A: Arm Label: controls; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: cases; Type: EXPERIMENTAL; Interventions: Behavioral: mindfulness based stress reduction (MBSR) | Intervention Type: BEHAVIORAL; Name: mindfulness based stress reduction (MBSR); Assigned to Arm(s): cases
B: Arm Label: Cognitive behavioral therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive behavioral therapy | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive behavioral therapy; Assigned to Arm(s): Cognitive behavioral therapy
C: Arm Label: Audio Relaxation technique; Type: EXPERIMENTAL; Interventions: Behavioral: Audio Relaxation Technique | Arm Label: Medical Music Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Medical Music Intervention | Arm Label: Nature Therapy without Music; Type: EXPERIMENTAL; Interventions: Behavioral: Nature Therapy without Music | Arm Label: Nature Therapy with Music; Type: EXPERIMENTAL; Interventions: Behavioral: Nature Therapy with Music | Intervention Type: BEHAVIORAL; Name: Audio Relaxation Technique; Assigned to Arm(s): Audio Relaxation technique | Intervention Type: BEHAVIORAL; Name: Medical Music Intervention; Assigned to Arm(s): Medical Music Intervention | Intervention Type: BEHAVIORAL; Name: Nature Therapy without Music; Assigned to Arm(s): Nature Therapy without Music | Intervention Type: BEHAVIORAL; Name: Nature Therapy with Music; Assigned to Arm(s): Nature Therapy with Music
D: Arm Label: THA Physiotherapy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: THA Physiotherapy, Procedure: No physiotherapy after THA | Arm Label: No physiotherapy after THA; Type: ACTIVE_COMPARATOR; Interventions: Procedure: No physiotherapy after THA | Intervention Type: PROCEDURE; Name: THA Physiotherapy; Assigned to Arm(s): THA Physiotherapy | Intervention Type: PROCEDURE; Name: No physiotherapy after THA; Assigned to Arm(s): No physiotherapy after THA, THA Physiotherapy

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Trial to Evaluate the Use of Plastic Bags in Preventing and Treating Hypothermia in Neonates in Developing Countries
Brief Summary: The overall hypothesis is that placing infants 1000-2500 grams in plastic bags when compared to routine care will reduce the risk of hypothermia (\< 36.5 degrees C) without increasing hyperthermia (\> 37.5 degrees C).


Options:
A: Arm Label: Resuscitation with plastic bag; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Resuscitation and post resuscitation care with plastic bag | Arm Label: Standard resuscitation- no plastic bag; Type: SHAM_COMPARATOR; Interventions: Procedure: Resuscitation- no plastic bag for temperature regulation | Intervention Type: PROCEDURE; Name: Resuscitation and post resuscitation care with plastic bag; Assigned to Arm(s): Resuscitation with plastic bag | Intervention Type: PROCEDURE; Name: Resuscitation- no plastic bag for temperature regulation; Assigned to Arm(s): Standard resuscitation- no plastic bag
B: Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: TK as soon as possible within 24 hours after birth | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional care | Intervention Type: BEHAVIORAL; Name: TK as soon as possible within 24 hours after birth; Assigned to Arm(s): A | Intervention Type: OTHER; Name: Conventional care; Assigned to Arm(s): B
C: Arm Label: cap; Type: EXPERIMENTAL; Interventions: Device: Polyethylene cap | Arm Label: wrap; Type: ACTIVE_COMPARATOR; Interventions: Device: Polyethylene wrap | Arm Label: conventional group; Type: OTHER; Interventions: Other: conventional treatment | Intervention Type: DEVICE; Name: Polyethylene cap; Assigned to Arm(s): cap | Intervention Type: DEVICE; Name: Polyethylene wrap; Assigned to Arm(s): wrap | Intervention Type: OTHER; Name: conventional treatment; Assigned to Arm(s): conventional group
D: Intervention Type: BEHAVIORAL; Name: Newborn Thermal Care Practice; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Double Blind Randomized Trial of Wound Infiltration With Ropivacaine After Breast Cancer Surgery
Brief Summary: Prospective double blind randomized evaluation of the effect of surgical wound infiltration with ropivacaine versus placebo in patients scheduled for breast surgery with axillary lymph node dissection


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: chirocaine (Levobupivacaine) | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: sodium chloride | Intervention Type: DRUG; Name: chirocaine (Levobupivacaine); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: sodium chloride; Assigned to Arm(s): 2
B: Arm Label: ropivacaine; Type: ACTIVE_COMPARATOR; Interventions: Procedure: infiltration with ropivacaine solution | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Procedure: infiltration with ropivacaine solution | Intervention Type: PROCEDURE; Name: infiltration with ropivacaine solution; Assigned to Arm(s): placebo, ropivacaine
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Lidocaine; Type: EXPERIMENTAL; Interventions: Drug: Lidocaine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Lidocaine; Assigned to Arm(s): Lidocaine
D: Arm Label: Patients who had inguinal herniorraphy.; Type: N/A; Interventions: Procedure: Inguinal herniorraphy. | Arm Label: Patients who had hysterectomy.; Type: N/A; Interventions: Procedure: Hysterectomy. | Arm Label: Patients who had thoracotomy.; Type: N/A; Interventions: Procedure: Thoracotomy . | Intervention Type: PROCEDURE; Name: Inguinal herniorraphy.; Assigned to Arm(s): Patients who had inguinal herniorraphy. | Intervention Type: PROCEDURE; Name: Hysterectomy.; Assigned to Arm(s): Patients who had hysterectomy. | Intervention Type: PROCEDURE; Name: Thoracotomy .; Assigned to Arm(s): Patients who had thoracotomy.

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Double Blind Randomized Trial of Wound Infiltration With Ropivacaine After Breast Cancer Surgery
Brief Summary: Prospective double blind randomized evaluation of the effect of surgical wound infiltration with ropivacaine versus placebo in patients scheduled for breast surgery with axillary lymph node dissection


Options:
A: Arm Label: Injection with Saline; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Infiltration with Saline | Arm Label: Injection with Bupivacaine; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Infiltration with Bupivacaine | Intervention Type: PROCEDURE; Name: Infiltration with Saline; Assigned to Arm(s): Injection with Saline | Intervention Type: PROCEDURE; Name: Infiltration with Bupivacaine; Assigned to Arm(s): Injection with Bupivacaine
B: Arm Label: ropivacaine; Type: ACTIVE_COMPARATOR; Interventions: Procedure: infiltration with ropivacaine solution | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Procedure: infiltration with ropivacaine solution | Intervention Type: PROCEDURE; Name: infiltration with ropivacaine solution; Assigned to Arm(s): placebo, ropivacaine
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Lidocaine; Type: EXPERIMENTAL; Interventions: Drug: Lidocaine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Lidocaine; Assigned to Arm(s): Lidocaine
D: Arm Label: Group L; Type: EXPERIMENTAL; Interventions: Drug: Systemic intravenous lidocaine infusion | Arm Label: Group C; Type: PLACEBO_COMPARATOR; Interventions: Drug: normal saline infusion | Intervention Type: DRUG; Name: Systemic intravenous lidocaine infusion; Assigned to Arm(s): Group L | Intervention Type: DRUG; Name: normal saline infusion; Assigned to Arm(s): Group C

Answer: B